ABT 102 |
| カタログ番号GB40088 |
一連の臨床試験で、一過性受容体ポテンシャルバニロイド1（TRPV1）受容体の強力かつ選択的な拮抗剤（IC50値は5〜7 nM）です。TRVP1受容体の拮抗作用は、疼痛管理における有望なアプローチです。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 808756-71-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Potent and selective antagonist of transient receptor potential vanilloid 1 (TRPV1) receptors (IC50 values to be 5-7 nM) under clinical trials; TRVP1 receptor antagonism is a promising approach for pain management
Review for ABT 102
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for ABT 102
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *